Industry Research Reports

Home > Reports > Chemical & Material > Global Metal-chelating Peptides(MCP) Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Metal-chelating Peptides(MCP) Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 152 Pages

Report ld: 4857613

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Metal-chelating Peptides(MCP) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.

From a downstream perspective, Molecular Imaging accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Metal-chelating Peptides(MCP) leading manufacturers including Rdcthera, Bachem, Bio-Synthesis, CPC Scientific Inc, Creative Peptides, WuXi TIDES, Genscript, JPT Peptide Technologies, Smartox Biotechnology, Pepscan, etc., dominate supply; the top five capture approximately % of global revenue, with Rdcthera leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Metal-chelating Peptides(MCP) market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Rdcthera
Bachem
Bio-Synthesis
CPC Scientific Inc
Creative Peptides
WuXi TIDES
Genscript
JPT Peptide Technologies
Smartox Biotechnology
Pepscan
Allpeptide
Wuhan Bioyeargene Biotechnology Co.,Ltd
Science Peptide
NJ Bio

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

DOTA
NOTA
DTPA
Other

Segment by Application

Molecular Imaging
Drug Delivery
Vaccine Development
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Metal-chelating Peptides(MCP) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Metal-chelating Peptides(MCP): Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Metal-chelating Peptides(MCP) Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 DOTA

1.2.3 NOTA

1.2.4 DTPA

1.2.5 Other

1.3 Market Segmentation by Application

1.3.1 Global Metal-chelating Peptides(MCP) Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Molecular Imaging

1.3.3 Drug Delivery

1.3.4 Vaccine Development

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Metal-chelating Peptides(MCP) Revenue Estimates and Forecasts 2020-2031

2.2 Global Metal-chelating Peptides(MCP) Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Metal-chelating Peptides(MCP) Sales Estimates and Forecasts 2020-2031

2.4 Global Metal-chelating Peptides(MCP) Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Metal-chelating Peptides(MCP) Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Metal-chelating Peptides(MCP) Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Metal-chelating Peptides(MCP) Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 DOTA Market Size by Manufacturers

4.5.2 NOTA Market Size by Manufacturers

4.5.3 DTPA Market Size by Manufacturers

4.5.4 Other Market Size by Manufacturers

4.6 Global Metal-chelating Peptides(MCP) Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Metal-chelating Peptides(MCP) Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Metal-chelating Peptides(MCP) Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Metal-chelating Peptides(MCP) Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Metal-chelating Peptides(MCP) Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Metal-chelating Peptides(MCP) Sales and Revenue by Type (2020-2031)

7.4 North America Metal-chelating Peptides(MCP) Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Metal-chelating Peptides(MCP) Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Metal-chelating Peptides(MCP) Sales and Revenue by Type (2020-2031)

8.4 Europe Metal-chelating Peptides(MCP) Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Metal-chelating Peptides(MCP) Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Metal-chelating Peptides(MCP) Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Metal-chelating Peptides(MCP) Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Metal-chelating Peptides(MCP) Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Metal-chelating Peptides(MCP) Sales and Revenue by Type (2020-2031)

10.4 Central and South America Metal-chelating Peptides(MCP) Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Metal-chelating Peptides(MCP) Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Metal-chelating Peptides(MCP) Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Metal-chelating Peptides(MCP) Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Metal-chelating Peptides(MCP) Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Rdcthera

12.1.1 Rdcthera Corporation Information

12.1.2 Rdcthera Business Overview

12.1.3 Rdcthera Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.1.4 Rdcthera Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Rdcthera Metal-chelating Peptides(MCP) Sales by Product in 2024

12.1.6 Rdcthera Metal-chelating Peptides(MCP) Sales by Application in 2024

12.1.7 Rdcthera Metal-chelating Peptides(MCP) Sales by Geographic Area in 2024

12.1.8 Rdcthera Metal-chelating Peptides(MCP) SWOT Analysis

12.1.9 Rdcthera Recent Developments

12.2 Bachem

12.2.1 Bachem Corporation Information

12.2.2 Bachem Business Overview

12.2.3 Bachem Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.2.4 Bachem Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Bachem Metal-chelating Peptides(MCP) Sales by Product in 2024

12.2.6 Bachem Metal-chelating Peptides(MCP) Sales by Application in 2024

12.2.7 Bachem Metal-chelating Peptides(MCP) Sales by Geographic Area in 2024

12.2.8 Bachem Metal-chelating Peptides(MCP) SWOT Analysis

12.2.9 Bachem Recent Developments

12.3 Bio-Synthesis

12.3.1 Bio-Synthesis Corporation Information

12.3.2 Bio-Synthesis Business Overview

12.3.3 Bio-Synthesis Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.3.4 Bio-Synthesis Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Bio-Synthesis Metal-chelating Peptides(MCP) Sales by Product in 2024

12.3.6 Bio-Synthesis Metal-chelating Peptides(MCP) Sales by Application in 2024

12.3.7 Bio-Synthesis Metal-chelating Peptides(MCP) Sales by Geographic Area in 2024

12.3.8 Bio-Synthesis Metal-chelating Peptides(MCP) SWOT Analysis

12.3.9 Bio-Synthesis Recent Developments

12.4 CPC Scientific Inc

12.4.1 CPC Scientific Inc Corporation Information

12.4.2 CPC Scientific Inc Business Overview

12.4.3 CPC Scientific Inc Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.4.4 CPC Scientific Inc Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 CPC Scientific Inc Metal-chelating Peptides(MCP) Sales by Product in 2024

12.4.6 CPC Scientific Inc Metal-chelating Peptides(MCP) Sales by Application in 2024

12.4.7 CPC Scientific Inc Metal-chelating Peptides(MCP) Sales by Geographic Area in 2024

12.4.8 CPC Scientific Inc Metal-chelating Peptides(MCP) SWOT Analysis

12.4.9 CPC Scientific Inc Recent Developments

12.5 Creative Peptides

12.5.1 Creative Peptides Corporation Information

12.5.2 Creative Peptides Business Overview

12.5.3 Creative Peptides Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.5.4 Creative Peptides Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Creative Peptides Metal-chelating Peptides(MCP) Sales by Product in 2024

12.5.6 Creative Peptides Metal-chelating Peptides(MCP) Sales by Application in 2024

12.5.7 Creative Peptides Metal-chelating Peptides(MCP) Sales by Geographic Area in 2024

12.5.8 Creative Peptides Metal-chelating Peptides(MCP) SWOT Analysis

12.5.9 Creative Peptides Recent Developments

12.6 WuXi TIDES

12.6.1 WuXi TIDES Corporation Information

12.6.2 WuXi TIDES Business Overview

12.6.3 WuXi TIDES Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.6.4 WuXi TIDES Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 WuXi TIDES Recent Developments

12.7 Genscript

12.7.1 Genscript Corporation Information

12.7.2 Genscript Business Overview

12.7.3 Genscript Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.7.4 Genscript Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Genscript Recent Developments

12.8 JPT Peptide Technologies

12.8.1 JPT Peptide Technologies Corporation Information

12.8.2 JPT Peptide Technologies Business Overview

12.8.3 JPT Peptide Technologies Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.8.4 JPT Peptide Technologies Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 JPT Peptide Technologies Recent Developments

12.9 Smartox Biotechnology

12.9.1 Smartox Biotechnology Corporation Information

12.9.2 Smartox Biotechnology Business Overview

12.9.3 Smartox Biotechnology Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.9.4 Smartox Biotechnology Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Smartox Biotechnology Recent Developments

12.10 Pepscan

12.10.1 Pepscan Corporation Information

12.10.2 Pepscan Business Overview

12.10.3 Pepscan Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.10.4 Pepscan Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Pepscan Recent Developments

12.11 Allpeptide

12.11.1 Allpeptide Corporation Information

12.11.2 Allpeptide Business Overview

12.11.3 Allpeptide Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.11.4 Allpeptide Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Allpeptide Recent Developments

12.12 Wuhan Bioyeargene Biotechnology Co.,Ltd

12.12.1 Wuhan Bioyeargene Biotechnology Co.,Ltd Corporation Information

12.12.2 Wuhan Bioyeargene Biotechnology Co.,Ltd Business Overview

12.12.3 Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.12.4 Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Wuhan Bioyeargene Biotechnology Co.,Ltd Recent Developments

12.13 Science Peptide

12.13.1 Science Peptide Corporation Information

12.13.2 Science Peptide Business Overview

12.13.3 Science Peptide Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.13.4 Science Peptide Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Science Peptide Recent Developments

12.14 NJ Bio

12.14.1 NJ Bio Corporation Information

12.14.2 NJ Bio Business Overview

12.14.3 NJ Bio Metal-chelating Peptides(MCP) Product Models, Descriptions and Specifications

12.14.4 NJ Bio Metal-chelating Peptides(MCP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 NJ Bio Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Metal-chelating Peptides(MCP) Industry Chain

13.2 Metal-chelating Peptides(MCP) Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Metal-chelating Peptides(MCP) Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Metal-chelating Peptides(MCP) Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Metal-chelating Peptides(MCP) Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Metal-chelating Peptides(MCP) Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Metal-chelating Peptides(MCP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Metal-chelating Peptides(MCP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Metal-chelating Peptides(MCP) Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Metal-chelating Peptides(MCP) Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Metal-chelating Peptides(MCP) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 7. Global Metal-chelating Peptides(MCP) Sales by Region (2020-2025) & (kg)

Table 8. Global Metal-chelating Peptides(MCP) Sales by Region (2026-2031) & (kg)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Metal-chelating Peptides(MCP) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 11. Global Metal-chelating Peptides(MCP) Production by Region (2020-2025) & (kg)

Table 12. Global Metal-chelating Peptides(MCP) Production by Region (2026-2031) & (kg)

Table 13. Global Metal-chelating Peptides(MCP) Sales by Manufacturers (2020-2025) & (kg)

Table 14. Global Metal-chelating Peptides(MCP) Sales Share by Manufacturers (2020-2025)

Table 15. Global Metal-chelating Peptides(MCP) Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Metal-chelating Peptides(MCP) Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Metal-chelating Peptides(MCP) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metal-chelating Peptides(MCP) as of 2024)

Table 19. Global Metal-chelating Peptides(MCP) Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Metal-chelating Peptides(MCP) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)

Table 21. Key Manufacturers Metal-chelating Peptides(MCP) Manufacturing Base and Headquarters

Table 22. Global Metal-chelating Peptides(MCP) Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Metal-chelating Peptides(MCP) Sales by Type (2020-2025) & (kg)

Table 26. Global Metal-chelating Peptides(MCP) Sales by Type (2026-2031) & (kg)

Table 27. Global Metal-chelating Peptides(MCP) Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Metal-chelating Peptides(MCP) Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Metal-chelating Peptides(MCP) ASP by Type (2020-2031) & (US$/g)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Metal-chelating Peptides(MCP) Sales by Application (2020-2025) & (kg)

Table 32. Global Metal-chelating Peptides(MCP) Sales by Application (2026-2031) & (kg)

Table 33. Metal-chelating Peptides(MCP) High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Metal-chelating Peptides(MCP) Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Metal-chelating Peptides(MCP) Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Metal-chelating Peptides(MCP) ASP by Application (2020-2031) & (US$/g)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Metal-chelating Peptides(MCP) Growth Accelerators and Market Barriers

Table 40. North America Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Metal-chelating Peptides(MCP) Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Metal-chelating Peptides(MCP) Growth Accelerators and Market Barriers

Table 43. Europe Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Metal-chelating Peptides(MCP) Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Metal-chelating Peptides(MCP) Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Metal-chelating Peptides(MCP) Growth Accelerators and Market Barriers

Table 48. Southeast Asia Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Metal-chelating Peptides(MCP) Investment Opportunities and Key Challenges

Table 50. Central and South America Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Metal-chelating Peptides(MCP) Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Metal-chelating Peptides(MCP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Rdcthera Corporation Information

Table 54. Rdcthera Description and Major Businesses

Table 55. Rdcthera Product Models, Descriptions and Specifications

Table 56. Rdcthera Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 57. Rdcthera Sales Value Proportion by Product in 2024

Table 58. Rdcthera Sales Value Proportion by Application in 2024

Table 59. Rdcthera Sales Value Proportion by Geographic Area in 2024

Table 60. Rdcthera Metal-chelating Peptides(MCP) SWOT Analysis

Table 61. Rdcthera Recent Developments

Table 62. Bachem Corporation Information

Table 63. Bachem Description and Major Businesses

Table 64. Bachem Product Models, Descriptions and Specifications

Table 65. Bachem Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 66. Bachem Sales Value Proportion by Product in 2024

Table 67. Bachem Sales Value Proportion by Application in 2024

Table 68. Bachem Sales Value Proportion by Geographic Area in 2024

Table 69. Bachem Metal-chelating Peptides(MCP) SWOT Analysis

Table 70. Bachem Recent Developments

Table 71. Bio-Synthesis Corporation Information

Table 72. Bio-Synthesis Description and Major Businesses

Table 73. Bio-Synthesis Product Models, Descriptions and Specifications

Table 74. Bio-Synthesis Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 75. Bio-Synthesis Sales Value Proportion by Product in 2024

Table 76. Bio-Synthesis Sales Value Proportion by Application in 2024

Table 77. Bio-Synthesis Sales Value Proportion by Geographic Area in 2024

Table 78. Bio-Synthesis Metal-chelating Peptides(MCP) SWOT Analysis

Table 79. Bio-Synthesis Recent Developments

Table 80. CPC Scientific Inc Corporation Information

Table 81. CPC Scientific Inc Description and Major Businesses

Table 82. CPC Scientific Inc Product Models, Descriptions and Specifications

Table 83. CPC Scientific Inc Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 84. CPC Scientific Inc Sales Value Proportion by Product in 2024

Table 85. CPC Scientific Inc Sales Value Proportion by Application in 2024

Table 86. CPC Scientific Inc Sales Value Proportion by Geographic Area in 2024

Table 87. CPC Scientific Inc Metal-chelating Peptides(MCP) SWOT Analysis

Table 88. CPC Scientific Inc Recent Developments

Table 89. Creative Peptides Corporation Information

Table 90. Creative Peptides Description and Major Businesses

Table 91. Creative Peptides Product Models, Descriptions and Specifications

Table 92. Creative Peptides Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Creative Peptides Sales Value Proportion by Product in 2024

Table 94. Creative Peptides Sales Value Proportion by Application in 2024

Table 95. Creative Peptides Sales Value Proportion by Geographic Area in 2024

Table 96. Creative Peptides Metal-chelating Peptides(MCP) SWOT Analysis

Table 97. Creative Peptides Recent Developments

Table 98. WuXi TIDES Corporation Information

Table 99. WuXi TIDES Description and Major Businesses

Table 100. WuXi TIDES Product Models, Descriptions and Specifications

Table 101. WuXi TIDES Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 102. WuXi TIDES Recent Developments

Table 103. Genscript Corporation Information

Table 104. Genscript Description and Major Businesses

Table 105. Genscript Product Models, Descriptions and Specifications

Table 106. Genscript Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 107. Genscript Recent Developments

Table 108. JPT Peptide Technologies Corporation Information

Table 109. JPT Peptide Technologies Description and Major Businesses

Table 110. JPT Peptide Technologies Product Models, Descriptions and Specifications

Table 111. JPT Peptide Technologies Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 112. JPT Peptide Technologies Recent Developments

Table 113. Smartox Biotechnology Corporation Information

Table 114. Smartox Biotechnology Description and Major Businesses

Table 115. Smartox Biotechnology Product Models, Descriptions and Specifications

Table 116. Smartox Biotechnology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 117. Smartox Biotechnology Recent Developments

Table 118. Pepscan Corporation Information

Table 119. Pepscan Description and Major Businesses

Table 120. Pepscan Product Models, Descriptions and Specifications

Table 121. Pepscan Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 122. Pepscan Recent Developments

Table 123. Allpeptide Corporation Information

Table 124. Allpeptide Description and Major Businesses

Table 125. Allpeptide Product Models, Descriptions and Specifications

Table 126. Allpeptide Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 127. Allpeptide Recent Developments

Table 128. Wuhan Bioyeargene Biotechnology Co.,Ltd Corporation Information

Table 129. Wuhan Bioyeargene Biotechnology Co.,Ltd Description and Major Businesses

Table 130. Wuhan Bioyeargene Biotechnology Co.,Ltd Product Models, Descriptions and Specifications

Table 131. Wuhan Bioyeargene Biotechnology Co.,Ltd Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 132. Wuhan Bioyeargene Biotechnology Co.,Ltd Recent Developments

Table 133. Science Peptide Corporation Information

Table 134. Science Peptide Description and Major Businesses

Table 135. Science Peptide Product Models, Descriptions and Specifications

Table 136. Science Peptide Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 137. Science Peptide Recent Developments

Table 138. NJ Bio Corporation Information

Table 139. NJ Bio Description and Major Businesses

Table 140. NJ Bio Product Models, Descriptions and Specifications

Table 141. NJ Bio Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 142. NJ Bio Recent Developments

Table 143. Key Raw Materials Distribution

Table 144. Raw Materials Key Suppliers

Table 145. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 146. Milestones in Production Technology Evolution

Table 147. Distributors List

Table 148. Market Trends and Market Evolution

Table 149. Market Drivers and Opportunities

Table 150. Market Challenges, Risks, and Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Metal-chelating Peptides(MCP) Product Picture

Figure 2. Global Metal-chelating Peptides(MCP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. DOTA Product Picture

Figure 4. NOTA Product Picture

Figure 5. DTPA Product Picture

Figure 6. Other Product Picture

Figure 7. Global Metal-chelating Peptides(MCP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Molecular Imaging

Figure 9. Drug Delivery

Figure 10. Vaccine Development

Figure 11. Other

Figure 12. Metal-chelating Peptides(MCP) Report Years Considered

Figure 13. Global Metal-chelating Peptides(MCP) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 15. Global Metal-chelating Peptides(MCP) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Metal-chelating Peptides(MCP) Revenue Market Share by Region (2020-2031)

Figure 17. Global Metal-chelating Peptides(MCP) Sales (2020-2031) & (kg)

Figure 18. Global Metal-chelating Peptides(MCP) Sales (CAGR) by Region (2020-2031) (kg)

Figure 19. Global Metal-chelating Peptides(MCP) Sales Market Share by Region (2020-2031)

Figure 20. Global Metal-chelating Peptides(MCP) Capacity, Production and Utilization (2020-2031) & (kg)

Figure 21. Global Metal-chelating Peptides(MCP) Production Trend by Region (2020-2031) (kg)

Figure 22. Global Metal-chelating Peptides(MCP) Production Market Share by Region (2020-2031)

Figure 23. Production Capacity Enablers & Constraints

Figure 24. Metal-chelating Peptides(MCP) Production Growth Rate in North America (2020-2031) & (kg)

Figure 25. Metal-chelating Peptides(MCP) Production Growth Rate in Europe (2020-2031) & (kg)

Figure 26. Metal-chelating Peptides(MCP) Production Growth Rate in China (2020-2031) & (kg)

Figure 27. Metal-chelating Peptides(MCP) Production Growth Rate in Japan (2020-2031) & (kg)

Figure 28. Top 5 and Top 10 Manufacturers Metal-chelating Peptides(MCP) Sales Volume Market Share in 2024

Figure 29. Global Metal-chelating Peptides(MCP) Revenue Market Share Ranking (2024)

Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 31. DOTA Revenue Market Share by Manufacturer in 2024

Figure 32. NOTA Revenue Market Share by Manufacturer in 2024

Figure 33. DTPA Revenue Market Share by Manufacturer in 2024

Figure 34. Other Revenue Market Share by Manufacturer in 2024

Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 37. Global Metal-chelating Peptides(MCP) Sales Market Share by Type (2020-2031)

Figure 38. Global Metal-chelating Peptides(MCP) Revenue Market Share by Type (2020-2031)

Figure 39. Global Metal-chelating Peptides(MCP) Sales Market Share by Application (2020-2031)

Figure 40. Global Metal-chelating Peptides(MCP) Revenue Market Share by Application (2020-2031)

Figure 41. North America Metal-chelating Peptides(MCP) Sales YoY (2020-2031) & (kg)

Figure 42. North America Metal-chelating Peptides(MCP) Revenue YoY (2020-2031) & (US$ Million)

Figure 43. North America Top 5 Manufacturers Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) in 2024

Figure 44. North America Metal-chelating Peptides(MCP) Sales Volume (kg) by Type (2020- 2031)

Figure 45. North America Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 46. North America Metal-chelating Peptides(MCP) Sales Volume (kg) by Application (2020-2031)

Figure 47. North America Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 48. US Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 49. Canada Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 50. Mexico Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 51. Europe Metal-chelating Peptides(MCP) Sales YoY (2020-2031) & (kg)

Figure 52. Europe Metal-chelating Peptides(MCP) Revenue YoY (2020-2031) & (US$ Million)

Figure 53. Europe Top 5 Manufacturers Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) in 2024

Figure 54. Europe Metal-chelating Peptides(MCP) Sales Volume (kg) by Type (2020-2031)

Figure 55. Europe Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 56. Europe Metal-chelating Peptides(MCP) Sales Volume (kg) by Application (2020-2031)

Figure 57. Europe Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 58. Germany Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 59. France Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 60. U.K. Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 61. Italy Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 62. Russia Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 63. Asia-Pacific Metal-chelating Peptides(MCP) Sales YoY (2020-2031) & (kg)

Figure 64. Asia-Pacific Metal-chelating Peptides(MCP) Revenue YoY (2020-2031) & (US$ Million)

Figure 65. Asia-Pacific Top 8 Manufacturers Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) in 2024

Figure 66. Asia-Pacific Metal-chelating Peptides(MCP) Sales Volume (kg) by Type (2020- 2031)

Figure 67. Asia-Pacific Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 68. Asia-Pacific Metal-chelating Peptides(MCP) Sales Volume (kg) by Application (2020-2031)

Figure 69. Asia-Pacific Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 70. Indonesia Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 71. Japan Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 72. South Korea Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 73. China Taiwan Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 74. India Metal-chelating Peptides(MCP) Revenue (2020-2031) & (US$ Million)

Figure 75. Central and South America Metal-chelating Peptides(MCP) Sales YoY (2020-2031) & (kg)

Figure 76. Central and South America Metal-chelating Peptides(MCP) Revenue YoY (2020-2031) & (US$ Million)

Figure 77. Central and South America Top 5 Manufacturers Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) in 2024

Figure 78. Central and South America Metal-chelating Peptides(MCP) Sales Volume (kg) by Type (2021-2031)

Figure 79. Central and South America Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 80. Central and South America Metal-chelating Peptides(MCP) Sales Volume (kg) by Application (2020-2031)

Figure 81. Central and South America Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 82. Brazil Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 83. Argentina Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 84. Middle East, and Africa Metal-chelating Peptides(MCP) Sales YoY (2020-2031) & (kg)

Figure 85. Middle East and Africa Metal-chelating Peptides(MCP) Revenue YoY (2020-2031) & (US$ Million)

Figure 86. Middle East and Africa Top 5 Manufacturers Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) in 2024

Figure 87. Middle East and Africa Metal-chelating Peptides(MCP) Sales Volume (kg) by Type (2021-2031)

Figure 88. South America Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 89. Middle East and Africa Metal-chelating Peptides(MCP) Sales Volume (kg) by Application (2020-2031)

Figure 90. Middle East and Africa Metal-chelating Peptides(MCP) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 91. GCC Countries Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 92. Turkey Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 93. Egypt Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 94. South Africa Metal-chelating Peptides(MCP) Revenue (2020-2025) & (US$ Million)

Figure 95. Metal-chelating Peptides(MCP) Industry Chain Mapping

Figure 96. Regional Metal-chelating Peptides(MCP) Manufacturing Base Distribution (%)

Figure 97. Metal-chelating Peptides(MCP) Production Process

Figure 98. Regional Metal-chelating Peptides(MCP) Production Cost Structure

Figure 99. Channels of Distribution (Direct Vs Distribution)

Figure 100. Bottom-up and Top-down Approaches for This Report

Figure 101. Data Triangulation

Figure 102. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Metal-chelating Peptides(MCP) market? zhanKai

The top companies in the global Metal-chelating Peptides(MCP) market are Rdcthera、Bachem、Bio-Synthesis.

Related Reports

Global Metal-chelating Peptides(MCP) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Metal-chelating Peptides(MCP) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 155
USD 4900.00
(Single User License)
Global Metal-chelating Peptides(MCP) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Metal-chelating Peptides(MCP) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
Metal-chelating Peptides(MCP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metal-chelating Peptides(MCP) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 119
USD 3950.00
(Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2026
The global Metal-chelating Peptides(MCP) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 143
USD 2900.00
(Single User License)
Global Metal-chelating Peptides(MCP) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Metal-chelating Peptides(MCP) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 4250.00
(Single User License)
Metal-chelating Peptides(MCP) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metal-chelating Peptides(MCP) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 116
USD 3950.00
(Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2025
The global market for Metal-chelating Peptides(MCP) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2024
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published Date: 2024-10-27
Pages: 100
USD 2900.00
(Single User License)
Global Metal-chelating Peptides(MCP) Market Insights, Forecast to 2030
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published Date: 2024-10-27
Pages: 153
USD 4900.00
(Single User License)
Global and United States Metal-chelating Peptides(MCP) Market Report & Forecast 2024-2030
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published Date: 2024-10-27
Pages: 137
USD 4350.00
(Single User License)

Global Metal-chelating Peptides(MCP) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Metal-chelating Peptides(MCP) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 155
USD 4900.00 (Single User License)
Global Metal-chelating Peptides(MCP) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Metal-chelating Peptides(MCP) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
USD 4250.00 (Single User License)
Metal-chelating Peptides(MCP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metal-chelating Peptides(MCP) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 119
USD 3950.00 (Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2026
The global Metal-chelating Peptides(MCP) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 143
USD 2900.00 (Single User License)
Global Metal-chelating Peptides(MCP) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Metal-chelating Peptides(MCP) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 4250.00 (Single User License)
Metal-chelating Peptides(MCP) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metal-chelating Peptides(MCP) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 116
USD 3950.00 (Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2025
The global market for Metal-chelating Peptides(MCP) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 100
USD 2900.00 (Single User License)
Global Metal-chelating Peptides(MCP) Market Research Report 2024
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published: 2024-10-27
Pages: 100
USD 2900.00 (Single User License)
Global Metal-chelating Peptides(MCP) Market Insights, Forecast to 2030
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published: 2024-10-27
Pages: 153
USD 4900.00 (Single User License)
Global and United States Metal-chelating Peptides(MCP) Market Report & Forecast 2024-2030
Metal chelating peptides (MCPs) refer to peptides conjugated to metal chelates (DOTA, NOTA, etc.), and such modified peptides provide an attractive approach for cancer tissue imaging and therapeutic delivery of cytotoxic substances to cancer cells.
Published: 2024-10-27
Pages: 137
USD 4350.00 (Single User License)